Gesa J. Albers
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Functional immune changes are conserved in COVID-19 and trauma patients receiving intensive care.
Journal: Nature communications
Published: October 14, 2025
Protective Role for Itaconate During Inhaled Allergen Challenge.
Journal: Allergy
Published: March 26, 2025
Cigarette smoke components modulate the MR1-MAIT axis.
Journal: The Journal of experimental medicine
Published: May 24, 2024
Airway macrophage glycolysis controls lung homeostasis and responses to aeroallergen.
Journal: Mucosal immunology
Published: April 17, 2024
Itaconate as a key regulator of respiratory disease.
Journal: Clinical and experimental immunology
Published: May 25, 2023
Airway soluble CSF1R predicts progression in patients with idiopathic pulmonary fibrosis.
Journal: ERJ open research
Published: December 13, 2022
CYFRA 21-1 Predicts Progression in Idiopathic Pulmonary Fibrosis: A Prospective Longitudinal Analysis of the PROFILE Cohort.
Journal: American journal of respiratory and critical care medicine
Published: April 01, 2022
DNA Methylome Alterations Are Associated with Airway Macrophage Differentiation and Phenotype during Lung Fibrosis.
Journal: American journal of respiratory and critical care medicine
Published: July 19, 2021
Itaconate controls the severity of pulmonary fibrosis.
Journal: Science immunology
Published: April 10, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026